Hoogerbrugge P M, Poorthuis B J, Mulder A H, Wagemaker G, Dooren L J, Vossen J M, van Bekkum D W
Transplantation. 1987 May;43(5):609-14. doi: 10.1097/00007890-198705000-00001.
The correction of lysosomal enzyme deficiency was investigated for various organs of beta-glucuronidase-deficient C3H/Rij mice after allogeneic bone marrow transplantation from an enzymatically normal donor strain (C57BL/Rij). In the hemopoietic organs, the enzyme level increased to levels found in donor mice. In lung, kidney, liver, and peripheral nervous tissue, a significant increase in enzyme activity was seen to levels intermediate between those of donor and recipient. Increased enzyme activity was maintained throughout the observation period of 150 days. In skeletal muscle tissue, enzyme levels tended to be higher in recipient mice, but this increase was not significant for all data points. Bone marrow transplantation failed to significantly affect enzyme activity in central nervous system tissue. These data suggest that beneficial effects expected from bone marrow transplantation for lysosomal enzyme deficiencies depend on the type of tissue involved in the disease. In diseases severely affecting the central nervous system, cure may not be expected from bone marrow transplantation alone, whereas in diseases with only minimal central nervous system involvement, alleviation or prevention of clinical symptoms may occur.
在将酶正常的供体品系(C57BL/Rij)的同种异体骨髓移植到β-葡萄糖醛酸酶缺陷的C3H/Rij小鼠的各个器官后,研究了溶酶体酶缺陷的纠正情况。在造血器官中,酶水平升高到供体小鼠中的水平。在肺、肾、肝和周围神经组织中,酶活性显著增加至供体和受体之间的中间水平。在150天的观察期内,酶活性持续增加。在骨骼肌组织中,受体小鼠的酶水平往往较高,但并非所有数据点的这种增加都显著。骨髓移植未能显著影响中枢神经系统组织中的酶活性。这些数据表明,骨髓移植对溶酶体酶缺陷预期的有益效果取决于疾病所涉及的组织类型。在严重影响中枢神经系统的疾病中,仅靠骨髓移植可能无法治愈,而在仅轻微累及中枢神经系统的疾病中,可能会减轻或预防临床症状。